Senores Pharmaceuticals Q1 Results
- BSE: 544319
- NSE: SENORES
- ISIN: INE0RB801010
- Sector: Biotechnology & Drugs
BSE
1,472.55
9.95 (0.68%)
9.95 (0.68%)Volume8.27 K
Updated: Fri 11 Sep, 2026 | 15:29:27
NSE
1,470.507.40 (0.51%)
7.40 (0.51%)Volume1.35 L
Updated: Fri 11 Sep, 2026 | 15:29:58
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹180.21 Cr.(30.60%)
- Operating Profit₹43.82 Cr.(55.56%)
- Profit After Tax₹30.72 Cr.(55.70%)
- Operating Margin24.32%(19.11%)
Note: Comparison is on YoY basis
Quarterly - Senores Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 136.39 | 136.98 | -0.43% | 62.59 | 24.19% |
| Depreciation/ Amortization | 9.94 | 9.30 | 6.88% | 3.52 | 65.94% |
| Operating Income | 43.82 | 21.35 | 105.25% | 17.80 | 55.56% |
| Net Income | 30.72 | 31.61 | -2.82% | 10.72 | 55.70% |
| Other Operating Expenses Total | 30.82 | 31.16 | -1.09% | 12.42 | 48.03% |
| Net Income Before Taxes | 39.46 | 47.40 | -16.75% | 13.46 | 48.96% |
| Total Revenue | 180.21 | 158.33 | 13.82% | 80.39 | 30.60% |
| Selling/ General/ Admin Expenses Total | 29.91 | 30.31 | -1.32% | 12.03 | 38.15% |
| Diluted Normalized EPS | 6.60 | 6.60 | -0.06% | 3.39 | 43.48% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.